Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8417073 | 0.88 | ALDH1A1 (0.56) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| SCHEMBL9701218 | 0.81 | ALOX15 (0.37) | TSHRALDH1A1HSD17B10ALOX15TET2 | |
| SCHEMBL4494873 | 0.81 | TSHR (0.62) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| SCHEMBL19503488 | 0.80 | — | — | |
| SCHEMBL60441 | 0.80 | MGAM (0.48) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| Dimethyl Succinate SCHEMBL28185979 | 0.79 | TSHR (0.87) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| Dimethyl Succinate SCHEMBL28054469 | 0.79 | TSHR (1.00) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| Dimethyl Succinate SCHEMBL10213 | 0.79 | TSHR (1.00) | TSHRLMNAKDM4EALDH1A1HSD17B10 | |
| SCHEMBL273086 | 0.79 | TET2 (0.46) | TSHRLMNAALDH1A1HSD17B10MAPT | |
| SCHEMBL11694985 | 0.78 | MGAM (0.46) | TSHRLMNAKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0833870-B1 | POLYMERS FOR ANTIFOULING COATINGS AND A PROCESS FOR THE PREPARATION THEREOF | JOTUN AS (NO) | 1999-09-08 | — | — | EP | claimed |
| EP-0841380-B1 | Method of making polymeric binders and use thereof in antifouling paints | WITCO GMBH (DE) | 1999-08-25 | — | — | EP | claimed |
| EP-0841380-A1 | Method of making polymeric binders and use thereof in antifouling paints | Witco GmbH (DE) | 1998-05-13 | — | — | EP | claimed |
| US-3936403-A | Synthetic resin composition | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
| US-11639350-B2 | Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections | JANSSEN PHARMACEUTICA NV (BE) | 2023-05-02 | — | — | US | disclosed |
| US-11459315-B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | CONSTELLATION PHARMACEUTICALS, INC. (US) | 2022-10-04 | — | — | US | disclosed |
| US-20210230148-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS, INC. | 2021-07-29 | — | — | US | disclosed |
| US-20200172532-A1 | HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2020-06-04 | — | — | US | disclosed |
| US-20130049264-A1 | PROCESS FOR PRODUCING FLEXOGRAPHIC PRINTING PLATE PRECURSOR FOR LASER ENGRAVING, FLEXOGRAPHIC PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR MAKING FLEXOGRAPHIC PRINTING PLATE | FUJIFILM CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20120210894-A1 | RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND RELIEF PRINTING PLATE AND PROCESS FOR MAKING SAME | FUJIFILM CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-7846963-B2 | 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20100286207-A1 | Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2010-11-11 | — | — | US | disclosed |
| US-4335254-A | Polymerizable acryloyloxyarylenesulfonamides | EASTMAN KODAK COMPANY (US) | 1982-06-15 | — | — | US | disclosed |
| US-4289865-A | USEFUL IN RELIEF IMAGES OR AS BINDERS IN PHOTOGRAPHIC MATERIALS | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| US-4259469-A | DESIRABLE SOLUBILITY CHARACTERISTICS FOR USE IN PHOTOLITHOGRAPHY | EASTMAN KODAK COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4239848-A | CONTAINING AMINES WHICH REACT WITH CARBONYL GROUPS TO CROSSLINK POLYMER | EASTMAN KODAK COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4133687-A | Photographic elements having hydrophilic colloid layers containing compounds having activator precursors and hydrophobic developing agents uniformly loaded in latex polymer particles | EASTMAN KODAK COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4082551-A | GOOD ADHESION AND BLOCKING POSITIVE CHARGED PARTICLES | EASTMAN KODAK COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
| US-3956212-A | ALUMINA TRIHYDRATE, MOLDING MATERIALS | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-05-11 | — | — | US | disclosed |
| US-3936403-A | Synthetic resin composition | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286207-A1 | Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same | NOD2, BMP2, NOD1 | TSHR 3661/4885LMNA 574/4885KDM4E 3563/4885 |
| US-11459315-B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | TPMT, TET1, TET2 | TSHR 4512/4885LMNA 3290/4885KDM4E 93/4885 |
| US-20200172532-A1 | HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | HAVCR2, HCCS, PYGL | TSHR 4103/4885LMNA 3136/4885KDM4E 4001/4885 |
| US-11639350-B2 | Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections | HCCS, HAVCR2, NR1H4 | TSHR 3525/4885LMNA 2714/4885KDM4E 4181/4885 |
| US-20210230148-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | TPMT, TET1, TET2 | TSHR 4512/4885LMNA 3290/4885KDM4E 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.